Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
286 participants
OBSERVATIONAL
2020-01-08
2024-12-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
We aims to evaluate whether the diagnostic performance of RFR in the side branch lesion is non-inferior compared to that in the main vessel lesion RFR and FFR measurements will be performed to define functional significance in patients with side branch lesion with or without main vessel lesion
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Fractional Flow Reserve-guided Provisional Side Branch Intervention
NCT00351780
Diagnostic Accuracy of Quantitative Flow Ratio
NCT06305572
Resting Full-cycle Ratio (RFR)-Guided Revascularization
NCT06075160
Influence of FFR on the Clinical Outcome After Percutaneous Coronary Intervention
NCT01873560
Diagnostic Performance of On-site Automatic Coronary Computed Tomography Angiography-derived Fractional Flow Reserve
NCT06153927
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
This novel physiologic index without need of adenosine have a potential to widely spread of functional assessment for coronary artery stenosis in daily clinical practice, and simplify procedure in complex coronary artery disease. Therefore, we sought to investigate diagnostic performance of this novel physiologic index to define myocardial ischemia in coronary bifurcation lesion, which is one of complex lesion subset.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Resting full-cycle ration (RFR) measurments
RFR and FFR measurements in main vessel and side branch lesions
Other Intervention Names
Discover alternative or legacy names that may be used to describe the listed interventions across different sources.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
* Culprit vessel in acute coronary syndrome
* Donor vessel to supply chronic total occlusion lesion of non-target vessel
* Symptomatic valvular heart disease or cardiomyopathy
* Too much overlapping or severe tortuosity to disrupt quantitative coronary analysis
* Previous bypass surgery
20 Years
90 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Soon Chun Hyang University
OTHER
Keimyung University Dongsan Medical Center
OTHER
Hanyang University Seoul Hospital
OTHER
Sejong General Hospital
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Hyun Jong Lee
MD, PhD
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Sejong General Hospital
Bucheon-si, Gyeonggi-do, South Korea
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
PREDICTABLE Version 3.5
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.